154 related articles for article (PubMed ID: 12802932)
1. Intravascular lymphoma presenting with cauda equina syndrome: treated with CHOP and rituxan.
Davis TS
Leuk Lymphoma; 2003 May; 44(5):887-8. PubMed ID: 12802932
[No Abstract] [Full Text] [Related]
2. Rituximab-CHOP or two-weekly CHOP + G-CSF in aggressive lymphoma of the elderly?
Todeschini G; Gelio S; Tecchio C
Ann Oncol; 2004 Mar; 15(3):538-9. PubMed ID: 14998863
[No Abstract] [Full Text] [Related]
3. Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Vose JM; Link BK; Grossbard ML; Czuczman M; Grillo-Lopez A; Gilman P; Lowe A; Kunkel LA; Fisher RI
J Clin Oncol; 2001 Jan; 19(2):389-97. PubMed ID: 11208830
[TBL] [Abstract][Full Text] [Related]
4. Rituximab-CHOP or 2-weekly CHOP + G-CSF in aggressive lymphoma of the elderly?
Bernardi D; Giacalone A; Spina M; Tirelli U
Ann Oncol; 2004 Aug; 15(8):1298. PubMed ID: 15277275
[No Abstract] [Full Text] [Related]
5. The treatment of lymphoma complicating autoimmune disease: two birds with one stone?
Mikuls TR
Ann Oncol; 2007 Apr; 18(4):615-8. PubMed ID: 17355949
[No Abstract] [Full Text] [Related]
6. Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma.
Arcaini L; Orlandi E; Scotti M; Brusamolino E; Passamonti F; Burcheri S; Colombo N; Vanelli L; Sbalzarini G; Lazzarino M
Clin Lymphoma; 2004 Mar; 4(4):250-2. PubMed ID: 15072617
[TBL] [Abstract][Full Text] [Related]
7. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
8. Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.
Vose JM; Link BK; Grossbard ML; Czuczman M; Grillo-Lopez A; Fisher RI
Leuk Lymphoma; 2005 Nov; 46(11):1569-73. PubMed ID: 16236611
[TBL] [Abstract][Full Text] [Related]
9. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma.
Clin Adv Hematol Oncol; 2006 Jul; 4(7):536-8. PubMed ID: 17147240
[No Abstract] [Full Text] [Related]
10. Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma.
Ennishi D; Yokoyama M; Mishima Y; Watanabe C; Terui Y; Takahashi S; Takeuchi K; Ikeda K; Tanimoto M; Hatake K
Leuk Lymphoma; 2007 Nov; 48(11):2241-3. PubMed ID: 17990181
[No Abstract] [Full Text] [Related]
11. Echocardiographic findings of intracardiac mass.
Tanaka H; Kawai H; Ishida T; Yoshida A; Yokoyama M
J Cardiol; 2007 Aug; 50(2):155-7. PubMed ID: 17802700
[No Abstract] [Full Text] [Related]
12. Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphoma.
Shimada K; Kosugi H; Narimatsu H; Shimada S; Suzuki T; Ito M; Kinoshita T; Mori N; Naoe T
J Clin Exp Hematop; 2008 Apr; 48(1):25-8. PubMed ID: 18434690
[TBL] [Abstract][Full Text] [Related]
13. Tubulointerstitial capillaries limited intravascular lymphoma of the kidney.
Kimura Y; Takeuchi M; Matsue K
Int J Hematol; 2017 Nov; 106(5):589-590. PubMed ID: 28755205
[No Abstract] [Full Text] [Related]
14. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
15. Intravascular lymphomatosis presenting as an ascending cauda equina: conus medullaris syndrome: remission after biweekly CHOP therapy.
Nakahara T; Saito T; Muroi A; Sugiura Y; Ogata M; Sugiyama Y; Yamamoto T
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):403-6. PubMed ID: 10449569
[TBL] [Abstract][Full Text] [Related]
16. [Primary hepatic lymphoma - favorable outcome with chemotherapy plus rituximab].
Serrano-Navarro I; Rodríguez-López JF; Navas-Espejo R; Pérez-Jacoiste MA; Martínez-González MA; Grande C; Prieto S
Rev Esp Enferm Dig; 2008 Nov; 100(11):724-8. PubMed ID: 19159179
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in the treatment of diffuse large B-cell lymphomas.
Coiffier B
Semin Oncol; 2002 Feb; 29(1 Suppl 2):30-5. PubMed ID: 11842386
[TBL] [Abstract][Full Text] [Related]
18. Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Bunworasate U; Nakorn TN; Rojnuckarin P
Leuk Lymphoma; 2006 Jul; 47(7):1306-14. PubMed ID: 16923561
[TBL] [Abstract][Full Text] [Related]
19. Intensive chemotherapy with rituximab is safe and effective in AIDS non-Hodgkin's lymphoma.
Rey J; Charbonnier A; Schiano de Colella JM; Stoppa AM; Poizot-Martin I; Gastaut JA; Costello RT
AIDS; 2003 Sep; 17(13):2006-7. PubMed ID: 12960844
[No Abstract] [Full Text] [Related]
20. Primary effusion lymphoma (PEL) revisited: a hematologist's perspective.
Desai S; Freeman NJ
Clin Adv Hematol Oncol; 2004 Jan; 2(1):60-1. PubMed ID: 16163162
[No Abstract] [Full Text] [Related]
[Next] [New Search]